ATM and glioblastoma: The ATM-mediated DSB repair pathway in GBM cancer stem cells has also been shown to be abrogated by the ATM inhibitor KU-55933, leading to profound radiosensitization with enhancement ratios of 2.6–3.5, depending on the human GBM cell line tested [61].